Activated T cells Inhibit NK Cell‐mediated Tumour Rejection

Xiaoyang Wang, Jianjun Hu, Jin Yuan, Yanmeng Peng, Lin Gui, W F He, Jindong Tan, Gaoxing Luo, Jun WuScandinavian 2009 · DOI

Abstract

Previous studies have described the regulation of some T-cell subsets toward natural killer (NK) cells. Naturally occurring CD4(+)CD25(+) T regulatory cells can inhibit NK cell cytotoxicity, while activated interleukin-2 (IL-2) secreting T cells can stimulate NK cells. However, little is known about the impact of the integrity T-cell population on the final outcome of NK cell cytotoxicity. We thus examined the possible role of activated T cells in affecting NK cell cytotoxicity by mixed lymphocyte co-cultures in vitro and a B16 melanoma tumour model in vivo. In our study, activated T cells were found to be able to significantly inhibit NK cell cytotoxicity in vitro and blunt NK cell-mediated tumour rejection in vivo. The inhibition of NK cell function is a cell-cell contact dependent way. Results suggest that activated T cells may play an important role in limiting NK cell functions, which might be very significant for the design of biotherapy against tumour or infection in future.
BibTeX
@inproceedings{wang2009activated,
  author = {Xiaoyang Wang and Jianjun Hu and Jin Yuan and Yanmeng Peng and Lin Gui and W F He and Jindong Tan and Gaoxing Luo and Jun Wu},
  title = {{Activated T cells Inhibit NK Cell‐mediated Tumour Rejection}},
  booktitle = {Scandinavian},
  year = {2009},
  doi = {10.1111/j.1365-3083.2009.02227.x},
}

Loading related content...

Figure